Detalhe da pesquisa
1.
Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group.
Int J Cancer
; 149(6): 1322-1331, 2021 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34019698
2.
Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Onkologie
; 33(3): 89-93, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20215798
3.
Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.
Mol Oncol
; 11(2): 208-219, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28106345